Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a gentle zap to the back calm spastic muscles after spinal injury?

NCT ID NCT06214208

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a noninvasive electrical stimulation applied to the lower back can reduce spasticity (involuntary muscle activity), improve muscle strength, and lessen pain in people with spinal cord injury. Thirty-six participants will receive the stimulation over several sessions, and researchers will measure leg movement and reflexes before, during, and after treatment. The goal is to see if this simple technique can provide short-term relief without medication.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
transcutaneous spinal stimulation (electrical stimulation through the skin)
What this could lead to
If it works, this could point toward a non-drug way to ease muscle tightness and improve movement after spinal cord injury.
What could go wrong
This is a small, early-phase study with only 36 participants, so results may not apply to everyone. The effects are measured immediately after stimulation, so long-term benefits are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 36 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2024

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

16 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants must agree to allow use of health information. * Participants should be 16 years old or older. * Participants must have had a spinal cord injury (SCI) of any severity (AIS A, B, C, or D) that happened at least 3 months ago. * Objectively measurable spasticity in your legs. * Participants must inform the investigators if there is a change in medications during the study. * Participants must be able to follow instructions. * Participants must be able to communicate if pain or discomfort is experienced. Exclusion Criteria: * People with spinal issues that are getting worse, such as degenerative or progressive vascular disorders. * People neurological problems other than SCI. * People with an injury level is below T12. * People with un-treated or uncontrolled heart problems that the lead investigator believes could be affected by stimulation or affected by an increase in blood pressure. * People with bone or joint problems that would make it hard to follow the study plan. * Women who are pregnant or actively trying to become pregnant. * People with implanted stimulators (like a baclofen pump, spinal stimulator, heart defibrillator, or diaphragmatic pacemaker) * People with infection. * People with skin that is broken or wounds in the area of the body where stimulation is applied. * People who have or had certain types of cancer in the area of the body where stimulation will be applied. * People who have had botulinum toxin or numbing shots in the test leg or spine in the last 6 months * People who have had permanent spasticity treatment in the test leg or spine (like a certain type of surgery). * Other health issues that the lead investigator things could make it unsafe for you to join the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Spinal cord injuries are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Shepherd Center, Inc.

    RECRUITING

    Atlanta, Georgia, 30309, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.